Dubai: Dubai Health has announced a partnership with The Royal Marsden NHS Foundation Trust. This collaboration aims to support the clinical and operational development of the Hamdan Bin Rashid Cancer Hospital (HBRCH), Dubai’s first integrated comprehensive cancer hospital.
The Royal Marsden, a global leader in cancer diagnosis, treatment, research, and education, will work closely with Dubai Health to establish a model of excellence in cancer care at HBRCH. Their expertise will be applied across several key areas, including developing specialist, evidence-based models of care, and creating early diagnosis and treatment pathways that guide patients through every step of their journey.
The HBRCH will offer a full spectrum of care from early detection to treatment, recovery, and post-treatment support. A central aspect of this partnership is the development of a world-class team of cancer care professionals. This includes creating a robust workforce plan, advanced training programs, and a culture of continuous learning. Additionally, a cancer research program will be established to drive transformative advancements in cancer care.
Dr. Raja Easa Al Gurg, Chairperson of Al Jalila Foundation Board of Directors and Member of Dubai Health Board of Directors, stated, “We are honoured to join forces with The Royal Marsden. Their renowned expertise and approach to care perfectly complement our missions of care, learning, discovery, and giving. This partnership honors the generosity of our donors and moves us closer to achieving the Dubai Social Agenda 33 goal of a world-class healthcare system.”
Dame Cally Palmer, Chief Executive of The Royal Marsden, expressed her enthusiasm for the collaboration. “I am delighted that The Royal Marsden has been chosen to work with Dubai Health. This is an excellent opportunity for international collaboration and to establish a structure for this advanced, innovative hospital. Our integrated NHS and Private Care model, supported by research and academic infrastructure, delivers outstanding personalized care for our patients. Through this partnership, we aim to develop a long-term strategic relationship that will support specialized cancer care across Dubai.”
Set to open in 2026, the HBRCH will feature 50 clinics, 30 research areas, 60 infusion rooms, and 116 inpatient beds across a 56,000-square-meter campus. The hospital is poised to become a beacon of hope for cancer patients in the UAE and the region, spearheading a transformative shift in cancer care delivery with a strong focus on research and clinical trials.